Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Two groups of women with preterm labor will be included. One will receive magnesium sulfate
for neuroprotection and the other will receive placebo. Fetal middle cerebral artery Doppler
indices will be measured before and after intake of either magnesium sulfate or placebo to
find if any significant changes occur in fetal cerebral blood flow.